These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33433319)

  • 1. Tumoral calcinosis due to severe hyperphosphatemia and secondary hyperparathyroidism without vascular calcification in a hemodialysis patient.
    Saito T; Mizobuchi M; Hamada T; Sugiyama M; Miyazawa N; Morikawa T; Matsumoto K; Yoshitake O; Aoki T; Murakami M; Honda H
    Clin Nephrol; 2021 Mar; 95(3):166-170. PubMed ID: 33433319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
    Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
    Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular calcification in dialysis patients.
    Al Humoud H; Al-Hilali N; Ahmad AA; Ninan VT; Nampoory MR; Rizk AM; Ali JH; Johny KV
    Transplant Proc; 2005 Dec; 37(10):4183-6. PubMed ID: 16387073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumoral calcinosis, calciphylaxis, hyperparathyroidism and tuberculosis in a dialysis patient.
    Kammoun K; Jarraya F; Hmida MB; Khebir A; Kharrat M; Boudawara T; Mnif J; Hachicha J
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):306-10. PubMed ID: 21422631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
    Iseki K
    Expert Opin Pharmacother; 2008 Mar; 9(4):601-10. PubMed ID: 18312161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac and pulmonary calcification in a hemodialysis patient: partial regression 4 years after parathyroidectomy.
    Di Leo C; Gallieni M; Bestetti A; Tagliabue L; Cozzolino M; Carpani P; Pozzato C; Tarolo GL; Brancaccio D
    Clin Nephrol; 2003 Jan; 59(1):59-63. PubMed ID: 12572933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete reversal of tumoral calcinosis after subtotal parathyroidectomy in a hemodialysis patient.
    Younes M; Belghali S; Zrour-Hassen S; Béjia I; Touzi M; Bergaoui N
    Joint Bone Spine; 2008 Oct; 75(5):606-9. PubMed ID: 18693124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.
    Hruska KA; Mathew S; Davies MR; Lund RJ
    Kidney Int Suppl; 2005 Dec; (99):S142-51. PubMed ID: 16336568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of treatment with calcimimetics on hyperparathyroidism and vascular mineralization.
    de Francisco AL; Piñera C; Palomar R; Arias M
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S281-5. PubMed ID: 17130275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of 10 patients with uremic tumoral calcinosis].
    Xiong M; Wang J; Li XD; Yu YW; Zhang L
    Zhonghua Nei Ke Za Zhi; 2020 Nov; 59(11):860-865. PubMed ID: 33120489
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
    Enevoldsen LH; Heaf J; Højgaard L; Zerahn B; Hasbak P
    Clin Physiol Funct Imaging; 2017 Mar; 37(2):131-136. PubMed ID: 26148143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinacalcet reduces vascular and soft tissue calcification in secondary hyperparathyroidism (SHPT) in hemodialysis patients.
    Aladrén Regidor MJ
    Clin Nephrol; 2009 Feb; 71(2):207-13. PubMed ID: 19203518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor-like bursal calcifications due to uncontrollable hyperphosphatemia in chronic hemodialysis. Case report].
    Frühwald F; Kovarik J; Neuhold A; Seidl G
    Radiologe; 1983 Nov; 23(11):529-31. PubMed ID: 6647838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical tumoral calcinosis with secondary hyperparathyroidism in a chronic hemodialysis patient.
    Sunder S; Verma H; Venkataramanan K
    Hemodial Int; 2013 Jul; 17(3):458-62. PubMed ID: 23072397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of tumoral calcinosis using CAPD combined with hemodialysis with low-calcium dialysate.
    Kuriyama S; Tomonari H; Nakayama M; Kawaguchi Y; Sakai O
    Blood Purif; 1998; 16(1):43-8. PubMed ID: 9513762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroidectomy in the Management of Secondary Hyperparathyroidism.
    Lau WL; Obi Y; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2018 Jun; 13(6):952-961. PubMed ID: 29523679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Front line of management of hyperphosphatemia in hemodialysis patients].
    Yumita S
    Clin Calcium; 2004 May; 14(5):771-7. PubMed ID: 15577041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recuperation of severe tumoral calcinosis in a dialysis patient: A case report.
    Westermann L; Isbell LK; Breitenfeldt MK; Arnold F; Röthele E; Schneider J; Widmeier E
    World J Clin Cases; 2019 Dec; 7(23):4004-4010. PubMed ID: 31832402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumoral calcifications in hemodialysis patients: possible role of aluminum intoxication.
    Zins B; Zingraff J; Basile C; Petitclerc T; Ureña P; Bardin T; Drüeke T
    Nephron; 1992; 60(3):260-7. PubMed ID: 1565177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.